BETIMOL Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
BETIMOL General Information
Description
A medicine brand in Osaka, Japan. The asset is a prescription eye drop medicine used to reduce pressure inside the eye in patients with ocular hypertension or open-angle glaucoma. The primary ingredient of the asset is timolol hemihydrate and is available in concentrations of 0.25% and 0.5%.
Contact Information
Corporate Office
- Osaka
- Japan
Corporate Office
- Osaka
- Japan
BETIMOL Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
BETIMOL Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
BETIMOL FAQs
-
Where is BETIMOL headquartered?
BETIMOL is headquartered in Osaka, Japan.
-
What industry is BETIMOL in?
BETIMOL’s primary industry is Buildings and Property.
-
Is BETIMOL a private or public company?
BETIMOL is a Private company.
-
What is the current valuation of BETIMOL?
The current valuation of BETIMOL is
. -
What is BETIMOL’s current revenue?
The current revenue for BETIMOL is
. -
Who are BETIMOL’s investors?
Santen has invested in BETIMOL.
-
When was BETIMOL acquired?
BETIMOL was acquired on 02-Jan-2014.
-
Who acquired BETIMOL?
BETIMOL was acquired by Akorn.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »